ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Spectrum Pharmaceuticals, Inc.
NEW YORK, April 25, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Spectrum Pharmaceuticals, Inc. SPPI and its board of directors concerning the proposed acquisition of the company by Assertio Holdings, Inc. ASRT. Stockholders will receive 0.1783 shares of Assertio Holdings common stock and a contingent value right up to $0.20 for each share of Spectrum Pharmaceuticals stock that they hold. The transaction is expected to close in the third quarter of 2023.
If you are a stockholder of Spectrum Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/sppi/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View original content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-spectrum-pharmaceuticals-inc-301807499.htmlSOURCE Rowley Law PLLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.